KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2022
2023 KLAS Emerging Solutions Top 20
Author
Steve Low
Author
Kyle Chilton
The partnerships that healthcare organizations make with technology vendors and services firms drive outcomes for years to come, and amid a flood of new technologies, great potential partners can be missed. In 2022, KLAS published the first Emerging Solutions Top 20 report, which showed the results of prominent members of the healthcare community reading KLAS reports on emerging technology and rating their perception of the solutions based on their potential to impact the Quadruple Aim of Healthcare: to improve outcomes, reduce the cost of care, improve the patient experience, and improve the clinician experience. The 2023 Emerging Solutions Top 20 report (1) ranks emerging solutions by their potential to disrupt the healthcare market and (2) provides insights from participating healthcare leaders into what innovation themes organizations should be aware of as they seek to provide the best patient care. For this report, 35 provider thought leaders with broad HIT experience read and rated 28 KLAS reports on emerging solutions.
If you don't have a login, getting started is easy.
Key Findings:
- 2023 KLAS Emerging Solutions Top 20
- Top 5-Improve Outcomes
- Top 5-Reduce the Cost of Care
- Top 5-Improve Patient Experience
- Top 5-Improve Clinician Experience
- All Eligible Solutions
- Participating Provider Thought Leaders
- Technology Innovation Themes
Writer
Carlisa Cramer
Designer
Jessica Bonnett
Project Manager
Kyle Chilton
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.